Literature DB >> 16690361

Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum.

Maha E Osman1, Frank P Mockenhaupt, Ulrich Bienzle, Mustafa I Elbashir, Hayder A Giha.   

Abstract

Mutations in the Plasmodium falciparum pfcrt gene on chromosome 7 and possibly mutations in pfmdr1 on chromosome 5 have a role in conferring resistance against chloroquine (CQ), as do mutations of pfdhfr on chromosome 4 and pfdhps on chromosome 8 in terms of resistance against sulfadoxine/pyrimethamine (SP). The additive role of multiple mutations in the development of resistance to each drug suggests a non-random occurrence. In this study, parasite isolates were obtained from 50 patients with uncomplicated P. falciparum malaria from rural Eastern Sudan, an endemic setting with minimal overlap of infection. The parasite isolates were genotyped for detection of 12 alleles in CQ and SP resistance genes. Our main findings were: (1) the frequency of mutant alleles, pfcrt K76T, pfmdr1 N86Y, pfdhfr N51I, pfdhfr S108N, pfdhps K540E and pfdhps A581G were; 0.90, 0.86, 0.84, 0.84, 0.80 and 0.20, respectively. (2) No mutations were detected for the pfdhfr loci A16V, C59R and I164L, and for pfdhps loci S436A, A437G and A613S. (3) There was a statistically significant association between the mutations in: (i) the CQ resistance (CQR) genes, pfcrt T76 and pfmdr1 Y86 (P< or =0.001), (ii) the SP resistance (SPR) genes, pfdhfr I51, pfdhfr N108 and pfdhps E540 (P< or =0.001-0.04) and (iii) the CQ "i" and SP "ii" resistance genes (P=0.001) 4. The fitness cost of multiple mutations was revealed by a significantly reduced parasite density of isolates bearing the mutant alleles (P=0.048). However, the significantly higher gametocyte carriage rate among isolates with resistance mutations (P=0.001) is possibly an evolutionary mechanism for survival of mutant parasites.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16690361     DOI: 10.1016/j.meegid.2006.03.008

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  29 in total

1.  Malaria antifolate resistance with contrasting Plasmodium falciparum dihydrofolate reductase (DHFR) polymorphisms in humans and Anopheles mosquitoes.

Authors:  Sungano Mharakurwa; Taida Kumwenda; Mtawa A P Mkulama; Mulenga Musapa; Sandra Chishimba; Clive J Shiff; David J Sullivan; Philip E Thuma; Kun Liu; Peter Agre
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-07       Impact factor: 11.205

Review 2.  Drug-resistant malaria in Sudan: A review of evidence and scenarios for the future.

Authors:  Ahmed Awad Adeel
Journal:  Sudan J Paediatr       Date:  2012

3.  Frequency distribution of antimalarial drug resistance alleles among Plasmodium falciparum isolates from Gezira State, central Sudan, and Gedarif State, eastern Sudan.

Authors:  Michela Menegon; Albadawi A Talha; Carlo Severini; Sayed M Elbushra; Ahmed A Mohamedani; Elfatih M Malik; Tarig A Mohamed; Walther H Wernsdorfer; Giancarlo Majori; Bakri Y M Nour
Journal:  Am J Trop Med Hyg       Date:  2010-08       Impact factor: 2.345

Review 4.  PfCRT and its role in antimalarial drug resistance.

Authors:  Andrea Ecker; Adele M Lehane; Jérôme Clain; David A Fidock
Journal:  Trends Parasitol       Date:  2012-09-25

5.  Balancing drug resistance and growth rates via compensatory mutations in the Plasmodium falciparum chloroquine resistance transporter.

Authors:  Ines Petersen; Stanislaw J Gabryszewski; Geoffrey L Johnston; Satish K Dhingra; Andrea Ecker; Rebecca E Lewis; Mariana Justino de Almeida; Judith Straimer; Philipp P Henrich; Eugene Palatulan; David J Johnson; Olivia Coburn-Flynn; Cecilia Sanchez; Adele M Lehane; Michael Lanzer; David A Fidock
Journal:  Mol Microbiol       Date:  2015-05-20       Impact factor: 3.501

6.  Environmental, pharmacological and genetic influences on the spread of drug-resistant malaria.

Authors:  Tiago Antao; Ian M Hastings
Journal:  Proc Biol Sci       Date:  2010-11-17       Impact factor: 5.349

Review 7.  Artemisinin derivatives for treatment of uncomplicated Plasmodium falciparum malaria in Sudan: too early for too much hope.

Authors:  Hayder A Giha
Journal:  Parasitol Res       Date:  2009-12-15       Impact factor: 2.289

8.  Pyrimethamine-resistant dihydrofolate reductase enzymes of Plasmodium falciparum are not enzymatically compromised in vitro.

Authors:  Conner I Sandefur; Jason M Wooden; Isaac K Quaye; Worachart Sirawaraporn; Carol Hopkins Sibley
Journal:  Mol Biochem Parasitol       Date:  2007-03-20       Impact factor: 1.759

Review 9.  The interplay between drug resistance and fitness in malaria parasites.

Authors:  Philip J Rosenthal
Journal:  Mol Microbiol       Date:  2013-08-16       Impact factor: 3.501

10.  Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola.

Authors:  Paula Figueiredo; Carla Benchimol; Dinora Lopes; Luís Bernardino; Virgílio E do Rosário; Luís Varandas; Fátima Nogueira
Journal:  Malar J       Date:  2008-11-17       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.